Clinical Trial Update: Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating telmisartan's effect on left ventricular mass by MRI in patients with mild-to-moderate hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 4 | Status: TERMINATED